BreatheSuite is about to launch a 30-person test of its new inhaler technology, whose purpose is to ensure people use common inhaler devices correctly.
BreatheSuite is a new company based in St. John’s that has developed software and hardware that aim to correct the improper use of inhalers. If successful, it could improve treatment for the millions of people who suffer from asthma and chronic obstructive pulmonary disease, or COPD.
The company is also part of a trend in St. John’s we’ve been writing about: the increasing number of Memorial University students in STEM disciplines who are